Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

Open Access 01-12-2020 | Itraconazole | Case report

A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old woman

Authors: Shinji Sasada, Kenshiro Ohmura, Tomoyo Oguri, Yutaro Fujimoto, Saori Murata, Yumi Tsuchiya, Kota Ishioka, Saeko Takahashi, Morio Nakamura, Masahiro Kaji

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

Fungal infections are rarely reported as a complication of bronchial thermoplasty (BT) in patients without immunosuppressive comorbidity.

Case presentation

A 19-year-old woman college student was admitted to our hospital owing to uncontrolled severe asthma despite using the maximum dose of steroid inhalation. She experienced asthmatic attacks more frequently while cheerleading, which is an extracurricular activity. She received BT because she wanted to continue cheerleading. After the second BT session, she developed more sputum and cough. During the third session, white secretion and saccular bronchodilation appeared in the left lower bronchus. Aspergillus fumigatus was detected in the culture of the bronchial lavage sample, and saccular bronchodilation in the affected bronchus was observed on computed tomography (CT). Five months after the start of oral itraconazole, her subjective symptoms as well as her CT findings improved. Her asthma condition improved enough for the patient to continue cheerleading without exacerbation.

Conclusions

It is necessary to consider the possibility of respiratory tract infections including fungal infections after BT. Detailed observations of the entire bronchus and sample collection for microbial culture are highly recommended.
Literature
1.
go back to reference Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma. Am J Respir Crit Care Med. 2010;181:116–24.CrossRef Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma. Am J Respir Crit Care Med. 2010;181:116–24.CrossRef
2.
go back to reference Wechsler ME, Laviolette M, Rubin AS, et al. Bronchial thermoplasty—long term safety and effectiveness in severe persistent asthma. J Allergy Clin Immunol. 2013;132:1295–302.CrossRef Wechsler ME, Laviolette M, Rubin AS, et al. Bronchial thermoplasty—long term safety and effectiveness in severe persistent asthma. J Allergy Clin Immunol. 2013;132:1295–302.CrossRef
3.
go back to reference Iikura M, Hojo M, Nagano N, et al. Bronchial thermoplasty for severe uncontrolled asthma in Japan. Allergol Int. 2018;67:273–5.CrossRef Iikura M, Hojo M, Nagano N, et al. Bronchial thermoplasty for severe uncontrolled asthma in Japan. Allergol Int. 2018;67:273–5.CrossRef
4.
go back to reference Burn J, Sims AJ, Keltie K, et al. Procedural and shorttermsafety of bronchial thermoplasty in clinical practice: evidence from a national registry and hospital episode statistics. J Asthma. 2016;1:1–8. Burn J, Sims AJ, Keltie K, et al. Procedural and shorttermsafety of bronchial thermoplasty in clinical practice: evidence from a national registry and hospital episode statistics. J Asthma. 2016;1:1–8.
5.
go back to reference Matsubayashi S, Iikura M, Numata M, et al. A case of Aspergillus and Nocardia infections after bronchial thermoplasty. Respirol Case Rep. 2019;7:e00392.PubMed Matsubayashi S, Iikura M, Numata M, et al. A case of Aspergillus and Nocardia infections after bronchial thermoplasty. Respirol Case Rep. 2019;7:e00392.PubMed
6.
go back to reference Yamamoto S, Iikura M, Kakuwa T, et al. Can the number of radiofrequency activations predict serious adverse events after bronchial thermoplasty? A retrospective case-control study Pulm Ther. 2019;5:221–33.PubMed Yamamoto S, Iikura M, Kakuwa T, et al. Can the number of radiofrequency activations predict serious adverse events after bronchial thermoplasty? A retrospective case-control study Pulm Ther. 2019;5:221–33.PubMed
7.
go back to reference Goorsenberg AWM, d’Hooghe JNS, de Bruin DM, et al. Bronchial thermoplasty-induced acute airway effects assessed with optical coherence tomography in severe asthma. Respiration. 2018;15:1–7. Goorsenberg AWM, d’Hooghe JNS, de Bruin DM, et al. Bronchial thermoplasty-induced acute airway effects assessed with optical coherence tomography in severe asthma. Respiration. 2018;15:1–7.
8.
go back to reference Fairfax AJ, David V, Douce G, et al. Laryngeal Aspergillosis following high-dose inhaled fluticasone therapy for asthma. Thorax. 1999;54:860–1.CrossRef Fairfax AJ, David V, Douce G, et al. Laryngeal Aspergillosis following high-dose inhaled fluticasone therapy for asthma. Thorax. 1999;54:860–1.CrossRef
9.
go back to reference Leav BA, Fanburg B, Hadley S, et al. Invasive pulmonary Aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med. 2000;343:586.CrossRef Leav BA, Fanburg B, Hadley S, et al. Invasive pulmonary Aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med. 2000;343:586.CrossRef
Metadata
Title
A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old woman
Authors
Shinji Sasada
Kenshiro Ohmura
Tomoyo Oguri
Yutaro Fujimoto
Saori Murata
Yumi Tsuchiya
Kota Ishioka
Saeko Takahashi
Morio Nakamura
Masahiro Kaji
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01352-y

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.